Metals ions and neurodegeneration

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Biometals

• Publication date

  2007-02-09

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s10534-006-9033-zPMID 17294125
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• P4–386: Neuroprotective actions of an iron chelator against Alzheimer's disease–relevant insults

  2006cited by this paper
• Long-lasting neural and behavioral effects of iron deficiency in infancy.

  2006cited by this paper
• Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives.

  2005cited by this paper
• The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy

  2005cited by this paper
• Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice

  2005influential reference
• Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain

  2005cited by this paper
• Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease?

  2005cited by this paper
• Cytokine toxicity to oligodendrocyte precursors is mediated by iron

  2005cited by this paper
• Interleukin-1 and neuronal injury

  2005cited by this paper
• Protein–nucleic acid interactions

  2004cited by this paper
• The Role of Iron in the Pathogenesis of Experimental Allergic Encephalomyelitis and Multiple Sclerosis

  2004cited by this paper
• Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats.

  2004cited by this paper
• Interleukin-1β up-regulates iron efflux in rat C6 glioma cells through modulation of ceruloplasmin and ferroportin-1 synthesis

  2004cited by this paper
• Abnormal fibrils from scrapie-infected brain

  2004cited by this paper
• Metal and inflammatory targets for Alzheimer's disease.

  2004cited by this paper
• The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human beta-amyloid precursor protein transgenic mice.

  2004cited by this paper
• Progress towards a molecular-level structural understanding of amyloid fibrils.

  2004influential reference
• Waste green sands as reactive media for groundwater contaminated with trichloroethylene (TCE).

  2004cited by this paper
• Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease.

  2003cited by this paper
• Protein Folding and Disease: a view from the first Horizon Symposium

  2003cited by this paper
• Health action international

  2003cited by this paper
• Pre- and Postweaning Iron Deficiency Alters Myelination in Sprague-Dawley Rats

  2003cited by this paper
• Inflammation in central nervous system injury.

  2003cited by this paper
• Challenges and complexities of alpha-synuclein toxicity: new postulates in unfolding the mystery associated with Parkinson's disease.

  2003cited by this paper
• Neurodegenerative disorders of protein aggregation.

  2003cited by this paper
• Protein folding and misfolding

  2003cited by this paper
• A novel trivalent cation chelator Feralex dissociates binding of aluminum and iron associated with hyperphosphorylated tau of Alzheimer's disease.

  2003cited by this paper
• Copper binding to PrPC may inhibit prion disease propagation.

  2003cited by this paper
• Structure and texture of fibrous crystals formed by Alzheimer's abeta(11-25) peptide fragment.

  2003cited by this paper
• Amyloid-beta: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-beta.

  2003cited by this paper
• Amyloid-β: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-β

  2003cited by this paper
• APP processing and synaptic function.

  2003cited by this paper
• Dopamine-dependent neurotoxicity of α-synuclein: A mechanism for selective neurodegeneration in Parkinson disease

  2002influential reference
• Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

  2002cited by this paper
• Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

  2002cited by this paper
• An Iron-responsive Element Type II in the 5′-Untranslated Region of the Alzheimer's Amyloid Precursor Protein Transcript*

  2002cited by this paper
• Design of clinically useful iron(III)‐selective chelators

  2002influential reference
• Supramolecular structural constraints on Alzheimer's beta-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance.

  2002cited by this paper
• Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases.

  2002cited by this paper
• The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease

  2002cited by this paper
• Design, synthesis, and evaluation of novel 2-substituted 3-hydroxypyridin-4-ones: structure-activity investigation of metalloenzyme inhibition by iron chelators.

  2002cited by this paper
• Hydrogen peroxide‐mediated phosphorylation of ERK1/2, 
Akt/PKB and JNK in cortical neurones: dependence 
on Ca2+ and PI3‐kinase

  2002cited by this paper
• Metal complexing agents as therapies for Alzheimer's disease.

  2002cited by this paper
• Lipofuscin: mechanisms of age-related accumulation and influence on cell function.

  2002cited by this paper
• Development of a novel diffusion-based method to estimate the size of the aggregated Abeta species responsible for neurotoxicity.

  2002cited by this paper
• Structural and Dynamic Features of Alzheimer's Aβ Peptide in Amyloid Fibrils Studied by Site-directed Spin Labeling*

  2002cited by this paper
• The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

  2002cited by this paper
• Cellular and subcellular morphological localization of normal prion protein in rodent cerebellum

  2001cited by this paper
• Copper and prion disease.

  2001cited by this paper
• Metal-triggered Structural Transformations, Aggregation, and Fibrillation of Human α-Synuclein

  2001cited by this paper
• Impairment of the ubiquitin-proteasome system by protein aggregation.

  2001cited by this paper
• Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier.

  2001cited by this paper
• Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins.

  2001cited by this paper
• Shattuck lecture--neurodegenerative diseases and prions.

  2001cited by this paper
• Structure-activity investigation of the inhibition of 3-hydroxypyridin-4-ones on mammalian tyrosine hydroxylase.

  2001cited by this paper
• Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice

  2001cited by this paper
• Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins

  2001influential reference
• Evidence for a Partially Folded Intermediate in α-Synuclein Fibril Formation*

  2001cited by this paper
• Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum?

  2001cited by this paper
• Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

  2001cited by this paper
• Molecular Biology of Prion Disease

  2000cited by this paper
• Iron is a regulatory component of human IL-1beta production. Support for regional variability in the lung.

  2000cited by this paper
• Fiber diffraction of synthetic a-synuclein filaments shows amyloid-like cross-b conformation

  2000cited by this paper
• The role of oxidative stress in the toxicity induced by amyloid beta-peptide in Alzheimer's disease.

  2000cited by this paper
• Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation.

  2000cited by this paper
• MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson’s disease: neuroprotective strategies

  2000cited by this paper
• [Huntington disease. A review].

  2000cited by this paper
• Chelation and intercalation: complementary properties in a compound for the treatment of Alzheimer's disease.

  2000cited by this paper
• Amyloid fibrillogenesis: themes and variations.

  2000cited by this paper
• Iron Is a Regulatory Component of Human IL-1 β Production

  2000cited by this paper
• The Role of Iron in Neurodegeneration

  1999influential reference
• The Pivotal Role of Iron in NF‐κB Activation and Nigrostriatal Dopaminergic Neurodegeneration: Prospects for Neuroprotection in Parkinson's Disease with Iron Chelators

  1999cited by this paper
• The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction.

  1999cited by this paper
• The possible origin of free radicals from amyloid beta peptides in Alzheimer's disease.

  1999cited by this paper
• Investigation into the correlation between the structure of hydroxypyridinones and blood-brain barrier permeability.

  1999influential reference
• Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.

  1999cited by this paper
• Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates.

  1999cited by this paper
• Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

  1999cited by this paper
• Soluble Amyloid b Peptide Concentration as a Predictor of Synaptic Change in Alzheimer’s Disease

  1999cited by this paper
• Copper(II)-induced self-oligomerization of alpha-synuclein.

  1999cited by this paper
• Protofibrillar Intermediates of Amyloid β-Protein Induce Acute Electrophysiological Changes and Progressive Neurotoxicity in Cortical Neurons

  1999cited by this paper
• Protein misfolding and prion diseases.

  1999cited by this paper
• Antioxidants, oxidative stress, and degenerative neurological disorders.

  1999cited by this paper
• Translation of the Alzheimer Amyloid Precursor Protein mRNA Is Up-regulated by Interleukin-1 through 5′-Untranslated Region Sequences*

  1999cited by this paper
• Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer’s Disease

  1999cited by this paper
• Copper ( II )-induced self-oligomerization of α-synuclein

  1999cited by this paper
• Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

  1998cited by this paper
• Copper, iron and zinc in Alzheimer's disease senile plaques.

  1998cited by this paper
• A Generalised Increase in Protein Carbonyls in the Brain in Parkinson's but Not Incidental Lewy Body Disease

  1997cited by this paper
• The Relationship of Intracellular Iron Chelation to the Inhibition and Regeneration of Human Ribonucleotide Reductase*

  1996cited by this paper
• Activation of the CPP32 Apoptotic Protease by Distinct Signaling Pathways with Differential Sensitivity to Bcl-xL*

  1996cited by this paper
• Basal ganglia iron content in Parkinson's disease measured with magnetic resonance

  1996cited by this paper
• Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

  1996cited by this paper
• Neurodegeneration and Neuroprotection in Parkinson's Disease

  1996cited by this paper
• The Environment of the Lipoxygenase Iron Binding Site Explored with Novel Hydroxypyridinone Iron Chelators (*)

  1996cited by this paper
• Morphology and Toxicity of Aβ-(1-42) Dimer Derived from Neuritic and Vascular Amyloid Deposits of Alzheimer's Disease*

  1996cited by this paper
• Influence of lipophilicity on the bioavailability and disposition of orally active 3-hydroxypyridin-4-one metal chelators.

  1995cited by this paper
• Potential protection from toxicity by oral iron chelators.

  1995cited by this paper
• A Quantitative Analysis of Isoferritins in Select Regions of Aged, Parkinsonian, and Alzheimer's Diseased Brains

  1995cited by this paper
• Correlations of synaptic and pathological markers with cognition of the elderly.

  1995cited by this paper

• Silica nanoparticle-based hybrid probe for visual fluorometric Fe3+ detection in beverage samples.

  2025cites this paper
• Semax, a Copper Chelator Peptide, Decreases the Cu(II)-Catalyzed ROS Production and Cytotoxicity of aβ by Metal Ion Stripping and Redox Silencing

  2025cites this paper
• A multi-omics approach reveals impaired lipid metabolism and oxidative stress in a zebrafish model of Alexander disease

  2025cites this paper
• Simultaneous Detection of MAO-B and Soluble Aβ Oligomers Based on a Bimetallic Loaded ZIF-8 Core-Shell Probe.

  2025cites this paper
• Selenoproteins: Zoom-In to Their Metal-Binding Properties in Neurodegenerative Diseases

  2025cites this paper
• Artesunate alleviates Parkinson's disease by targeting astrocyte MT2A to attenuate dopamine neuronal cuproptosis.

  2025cites this paper
• A Hemicyanine‐Based Highly Sensitive and Selective Near‐Infrared Fluorescent Probe for Fe3+ in Aqueous Media

  2024cites this paper
• Chalcone-based Turn-Off Chemosensor for Selective and Susceptible Detection of Fe2+ Ions: Spectroscopic and DFT Investigations

  2024cites this paper
• Therapeutic modalities of deferiprone in Parkinson's disease: SKY and EMBARK studies

  2024cites this paper
• Theoretical insights into Zn2+chelated complexes of herbacetin for the application in Alzheimer's disease

  2023cites this paper
• Smouldering Lesion in MS: Microglia, Lymphocytes and Pathobiochemical Mechanisms

  2023cites this paper
• Synthesis of a Novel Hydrazone Functionality based Spectrophotometric Probe for Selective and Sensitive Estimation of Toxic Heavy Metal Ions

  2023cites this paper
• Bright, green fluorescent carbon dots for sensitive and selective detection of ferrous ions

  2023cites this paper
• Biophysical study on DNA and BSA binding activity of Cu(II) complex: Synthesis, molecular docking, cytotoxic activity, and theoretical approach

  2023cites this paper
• Epigallocatechin Gallate Modulates Microglia Phenotype to Suppress Pro-inflammatory Signalling Cues and Inhibit Phagocytosis

  2023cites this paper
• Distribution of Iron, Copper, Zinc and Cadmium in Glia, Their Influence on Glial Cells and Relationship with Neurodegenerative Diseases

  2023cites this paper
• Fabrication of multifunctional 3D-flower-shaped NaTb(MoO4)2:Dy3+@Phen and NaTb(WO4)2:Dy3+@Phen nanoparticle materials for efficacious luminescence sensing of Fe2+ ions and photocatalytic degradation of rhodamine B in an aqueous medium

  2023cites this paper
• Mercury ions impact the kinetic and thermal stabilities of human lens γ-crystallins via direct metal-protein interactions.

  2023cites this paper
• The Blood Concentration of Metallic Nanoparticles Is Related to Cognitive Performance in People with Multiple Sclerosis: An Exploratory Analysis

  2023cites this paper
• Salicylic acid doped silica nanoparticles as a fluorescent nanosensor for the detection of Fe3+ in aqueous solution.

  2023cites this paper
• The Neuroprotective Activities of the Novel Multi-Target Iron-Chelators in Models of Alzheimer’s Disease, Amyotrophic Lateral Sclerosis and Aging

  2023cites this paper
• Pleiotropic Potential of Evernia prunastri Extracts and Their Main Compounds Evernic Acid and Atranorin: In Vitro and In Silico Studies

  2023cites this paper
• Physiopathological changes of ferritin mRNA density and distribution in hippocampal astrocytes in the mouse brain

  2022cites this paper
• Resveratrol and neuroprotection: an insight into prospective therapeutic approaches against Alzheimer’s disease from bench to bedside

  2022cites this paper
• Fluorescent Carbon Dots for Sensitive and Rapid Monitoring of Intracellular Ferrous Ion

  2022cites this paper
• Long-Term Effects of Nanoscale Magnetite on Human Forebrain-like Tissue Development in Stem-Cell-Derived Cortical Spheroids.

  2022cites this paper
• Recent developments in the creation of a single molecular sensing tool for ternary Iron (III), Chromium (III), Aluminium (III) ionic species: a review.

  2022cites this paper
• A Water-Stable Eu-Mof As Multi-Responsive Luminescent Sensor for High-Efficiency Detection of Fe3+, Mno4- Ions and Nicosulfuron In Aqueous Solution

  2022cites this paper
• A review of plant metabolites with metal interaction capacity: a green approach for industrial applications

  2021cites this paper
• An activatable AIEgen probe for in-situ monitoring and long-term tracking of ferrous ions in living cells

  2021cites this paper
• Characterization of the binding affinity between some anti-Parkinson agents and Mn2+, Fe3+ and Zn2+ metal ions: A DFT insight

  2021cites this paper
• Importance of Biometals as Targets in Medicinal Chemistry: An Overview about the Role of Zinc (II) Chelating Agents

  2020cites this paper
• Iron Metabolism in Oligodendrocytes and Astrocytes, Implications for Myelination and Remyelination

  2020cites this paper
• Effects of Incubation of Human Brain Microvascular Endothelial Cells and Astrocytes with Pyridostigmine Bromide, DEET, or Permethrin in the Absence or Presence of Metal Salts

  2020cites this paper
• The Bidirectional Relationship Between Sleep and Inflammation Links Traumatic Brain Injury and Alzheimer’s Disease

  2020cites this paper
• Metal Imbalance in Neurodegenerative Diseases with a Specific Concern to the Brain of Multiple Sclerosis Patients

  2020cites this paper
• Colorimetric and fluorimetric dual mode detection of Fe2+ in aqueous solution based on a carbon dots/phenanthroline system

  2020cites this paper
• A differentially selective probe for trivalent chemosensor upon single excitation with cell imaging application: potential applications in combinatorial logic circuit and memory devices

  2019cites this paper
• Neuropathogenesis of Multiple Sclerosis and Huntington's Disease

  2019cites this paper
• Assessment of copper, iron, zinc and manganese status and speciation in patients with Parkinson's disease: A pilot study.

  2019cites this paper
• ASSOCIATION BETWEEN PARTICULATE MATTER AND ALZHEIMER'S DISEASE IN ELDERLY SUBJECTS

  2019cites this paper
• The first observation of electrochemistry of graphene/cysteine/copper composite

  2019cites this paper
• ZnMOF-74 responsive fluorescence sensing platform for detection of Fe3+

  2019cites this paper
• Curcumin: A multifaceted herbal medicine

  2019cites this paper
• Effective inhibition of copper-catalyzed production of hydroxyl radicals by deferiprone

  2019cites this paper
• Developing a simple and water soluble thiophene-functionalized Ru(II)-polypyridyl complex for ferric ion detection

  2019cites this paper
• Iron Metabolism in the Peripheral Nervous System: The Role of DMT1, Ferritin, and Transferrin Receptor in Schwann Cell Maturation and Myelination

  2019cites this paper
• Rational Design of Novel Selective Dual-Target Inhibitors of Acetylcholinesterase and Monoamine Oxidase B as Potential Anti-Alzheimer's Disease Agents.

  2018cites this paper
• Synthesis and characterisation of novel phenanthroline quinone derivatives and their evaluation as Alzheimer's disease therapeutic active ingredients

  2018cites this paper
• Oxidative stress and neurodegeneration: the involvement of iron

  2018cites this paper
• Selective sensing of lysosomal iron(III) via three-component fluorescence-based strategy in living cells

  2018cites this paper
• Discovery of novel propargylamine-modified 4-aminoalkyl imidazole substituted pyrimidinylthiourea derivatives as multifunctional agents for the treatment of Alzheimer's disease.

  2018cites this paper
• Synthesis, characterization and biological activity of copper(II) complexes with ligands derived from β-amino acids

  2018cites this paper
• Cellulose-Based Sensor Containing Phenanthroline for the Highly Selective and Rapid Detection of Fe2+ Ions with Naked Eye and Fluorescent Dual Modes.

  2018cites this paper
• Small Molecules: Therapeutic Application in Neuropsychiatric and Neurodegenerative Disorders

  2018cites this paper
• Prospective of SNCA in nervous system diseases

  2017cites this paper
• Iron in neurodegenerative disorders: being in the wrong place at the wrong time?

  2017cites this paper
• Evaluation of Different Factors Leading to the Genesis of Alzheimer’s Disease: Research Proposal on Dementia

  2017cites this paper
• Modelling iron mismanagement in neurodegenerative disease in vitro: paradigms, pitfalls, possibilities & practical considerations.

  2017cites this paper
• A BODIPY-based near infrared fluorescent probe for Fe3+ in water

  2017cites this paper
• In Vitro Antioxidant Properties of Novel Schiff Base Complexes

  2017cites this paper
• 2-Hydroxy-1-naphthaldehyde: A versatile building block for the development of sensors in supramolecular chemistry and molecular recognition

  2017cites this paper
• Synthesis, Characterization, and Cytotoxicity of Binuclear Cooper(II)-Complexes with some S-Alkenyl Derivatives of Thiosalicyclic Acid

  2017cites this paper
• Cell proliferation and metal accumulation in the subventricular zone and olfactory bulb in Parkinson’s disease

  2016cites this paper
• Dual Functional Biocomposites Based on Polydopamine Modified Cellulose Nanocrystal for Fe3+-Pollutant Detecting and Autoblocking

  2016cites this paper
• Orientation effect induced selective chelation of Fe2+ to a glutamic acid appended conjugated polymer for sensing and live cell imaging.

  2016cites this paper
• Coordination and redox properties of copper interaction with α-synuclein.

  2016cites this paper
• The epidemiology of amyotrophic lateral sclerosis in the Mount Etna region: a possible pathogenic role of volcanogenic metals

  2016cites this paper
• Design, synthesis and evaluation of 3,4-dihydroxybenzoic acid derivatives as antioxidants, bio-metal chelating agents and acetylcholinesterase inhibitors

  2015cites this paper
• How our bodies fight amyloidosis: effects of physiological factors on pathogenic aggregation of amyloidogenic proteins.

  2015cites this paper
• Iron is a specific cofactor for distinct oxidation- and aggregation-dependent Aβ toxicity mechanisms in a Drosophila model

  2015cites this paper
• Sulfur and selenium antioxidants: challenging radical scavenging mechanisms and developing structure-activity relationships based on metal binding.

  2015cites this paper
• Effects of aluminum on amyloid-beta aggregation in the context of Alzheimer’s disease

  2015cites this paper
• Fluorescent, MRI, and colorimetric chemical sensors for the first-row d-block metal ions.

  2015cites this paper
• Multifunctional novel Diallyl disulfide (DADS) derivatives with β-amyloid-reducing, cholinergic, antioxidant and metal chelating properties for the treatment of Alzheimer's disease.

  2015cites this paper
• Sugar conjugates of 3-hydroxy-4-pyridinones : synthesis and investigations into their potential for drug delivery to the brain

  2015cites this paper
• Design, synthesis and evaluation of multifunctional salphen derivatives for the treatment of Alzheimer's disease.

  2014cites this paper
• Rational Design of Copper and Iron Chelators to Treat Wilson's Disease and Hemochromatosis

  2014cites this paper
• Inhibitory effect of selenoprotein P on Cu(+)/Cu(2+)-induced Aβ42 aggregation and toxicity.

  2014cites this paper
• New Perspectives on Oxidized Genome Damage and Repair Inhibition by Pro-Oxidant Metals in Neurological Diseases

  2014cites this paper
• Ligand Design to Target and Modulate Metal–Protein Interactions in Neurodegenerative Diseases

  2014cites this paper
• Metal and complementary molecular bioimaging in Alzheimer's disease

  2014cites this paper
• Increased metal content in the TDP-43A315T transgenic mouse model of frontotemporal lobar degeneration and amyotrophic lateral sclerosis

  2014cites this paper
• Copper chelators: chemical properties and bio-medical applications.

  2014cites this paper
• Fluorescence Off-On Sensors for F-, K+, Fe3+, and Ca2+ Ions

  2014cites this paper
• The interactions of glycated decapeptide, the Amadori product, with copper(II) ions - a possible effect on the oxidative stress induced aggregation?

  2014cites this paper
• Novel BODIPY-based fluorescence turn-on sensor for Fe3+ and its bioimaging application in living cells.

  2014cites this paper
• Quantifying iron levels in the YAC128 mouse model of Huntington's Disease

  2014cites this paper
• mouse model of frontotemporal lobar degeneration and amyotrophic lateral sclerosis

  2014cites this paper
• Metals, oxidative stress and neurodegeneration: a focus on iron, manganese and mercury.

  2013cites this paper
• The biosensitivity of certain organs in rats exposed to low doses of γ-radiation

  2013cites this paper
• Roles of manganese and protein kinase signaling in cell culture and animal models of prion disease

  2013cites this paper
• A highly selective turn-on fluorescent probe for iron(II) to visualize labile iron in living cells

  2013cites this paper
• Altered manganese homeostasis and manganese toxicity in Huntington’s Disease striatal cell model are not due to defects in iron transport system

  2013cites this paper
• 6-Hydroxydopamine promotes iron traffic in primary cultured astrocytes

  2013cites this paper
• A rapid and sensitive detection of ferritin at a nanomolar level and disruption of amyloid β fibrils using fluorescent conjugated polymer

  2013cites this paper
• Acetylcholinesterase Inhibition and in Vitro and in Vivo Antioxidant Activities of Ganoderma lucidum Grown on Germinated Brown Rice

  2013cites this paper
• Copper coordination to the prion protein: Insights from theoretical studies

  2013cites this paper
• Selenoprotein P and selenoprotein M block Zn2+ -mediated Aβ42 aggregation and toxicity.

  2013cites this paper
• The relevance of metals in the pathophysiology of neurodegeneration, pathological considerations.

  2013cites this paper